Fig. 3 | British Journal of Cancer

Fig. 3

From: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965

Fig. 3

FDG PET showing extensive uptake in tumour metastases throughout the body on maximum intensity projections (a). Reduced uptake in the brain (b, c) is shown on the maximum intensity projection and fused axial images (hot iron scale) and compared with a cross section of FDG-avid nodal and bone metastases in the thorax (d, indicated by white arrows). The PET scan was performed on a GE 710 PET-CT scanner with a dose of 3.5 MBq/kg 18F fludeoxyglucose in 3-min bed positions.

Back to article page